Krystal Biotech looks for FDA approval for dystrophic epidermolysis bullosa treatment
U.S. gene therapy company Krystal Biotech, Inc, has submitted a Biologics License Application (BLA) to…
23/06/2022 - 3 minutes
U.S. gene therapy company Krystal Biotech, Inc, has submitted a Biologics License Application (BLA) to…